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Abstract: Over-the-counter non-steroidal anti-inflammatory drugs (NSAIDs) and paracetamol are most commonly the 
first-line pharmacotherapy in combating different pain and inflammatory disorders and fever. Unfortunately, those drugs 
might have serious side effects, especially when they are used in an inappropriate way. The aim of the study was to explore 
various aspects of NSAIDs and paracetamol use in the self-therapy of miscellaneous disorders in young adults. The ques-
tionnaire-based survey comprised 250 consecutive students aged 22.1 ± 1.9 years (189 women) of diverse fields of study. 
The drugs were applied in clinical conditions in which they should be avoided including asthma attack (1.2%), vomiting 
(2.4%), malaise and depression (3.6%), in autumn and winter as a preventive measure against infections (14.0%), heart-
burn (2.0%) and during food poisoning (16.0%). As many as 6.0% of the students claimed that studied medications are 
ultimately free of adverse reactions. Men more frequently than women used NSAIDs and paracetamol during alcohol 
consumption (49.2% vs 30.7%, p = 0.009, respectively) but less often were aware that there are maximum doses of med-
ications which should not be exceeded (57.4% vs 76.7%, p = 0.003, respectively). The students of medical-related degree 
courses (n = 82) compared with individuals of other subjects (n = 168) declared they more often have the custom of 
always reading medications’ leaflets (46.3% vs 31.0%, p = 0.017, respectively). Side effects of medicines were reported 
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by 65 participants — 26.0%. In conclusion, students’ knowledge about NSAIDs and paracetamol is low. Participants do 
not search for information on drug related endangerments, the medication group choice for the given disorder is often 
inappropriate and the drugs are applied in conditions in which they are contraindicated.
Key words: non-steroidal anti-inflammatory drugs, paracetamol, questionnaire, adverse effects, alcohol, package leaflet.
Introduction
Non-steroidal anti-inflammatory drugs (NSAIDs) form a group of medications with analgesic, 
antipyretic, anti-inflammatory actions and in most cases with platelet aggregation inhibitory 
properties [1, 2]. Paracetamol exerts only remarkable analgesic and antipyretic effects [3]. The 
most frequent indications for NSAIDs comprise acute and chronic inflammatory processes, 
whereas NSAIDs and paracetamol are most commonly the first-line pharmacotherapy in 
combating pain disorders of different origin and fever [4]. The list of contraindications to 
NSAIDs application is relatively short and includes active peptic ulcer disease, pregnancy 
and breast-feeding, severe liver and kidney insufficiency, allergy to NSAIDs and hemor-
rhagic diathesis. Paracetamol must not be utilized in hypersensitivity to any component of 
drug formulations, severe hepatic or renal failure, glucose-6-phosphate dehydrogenase or 
methemoglobin reductase deficiencies [5, 6]. 
NSAIDs and paracetamol are distributed via the over-the-counter sale (OTC) and are 
extremely popular [7]. Considering the number of drugs’ packages per person in Europe, 
Polish citizens are only surpassed by Frenchmen, while the Polish market alone of just 
paracetamol, ibuprofen and acetylsalicylic acid formulations exceeds 300 million US dollars 
yearly [8, 9]. Unfortunately, NSAIDs and paracetamol might have serious side effects involv-
ing not only gastrointestinal tract, kidneys, nervous system or hematological complications, 
but almost every organ, especially when they are used in an irrational way, with no respect 
to safety rules [10–13].
Although adverse reactions related to NSAIDs use are mainly associated with older 
people, they also concern adolescents and young adults [14]. The awareness of NSAIDs en-
dangerments in this part of population might reduce not only present but also future drugs 
complications. Nevertheless, available data on young people and students knowledge about 
NSAIDs and paracetamol are scarce and distressing [15, 16]. 
The aim of the study was to explore various aspects of NSAIDs and paracetamol appli-
cation in the self-therapy of different disorders in Polish students of different fields of study 
including disorders treated with the drugs, medications safety and efficacy, the medicines’ 
group choice, treatment restrictions, preparations dosing and adverse reactions. 
Material and methods 
A specially designed questionnaire with closed-ended questions was dispensed to the stu-
dents who consented to take part in the survey. It contained the table of most common trade 
names of OTC NSAIDs (section A) and paracetamol formulations (section B) on the Polish 
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market (Table 1) [6]. The combined drugs with an NSAID and paracetamol were placed in 
the section A and complex formulations containing paracetamol and other substances, but 
none of the NSAIDs, in the section B. The questionnaire was divided into sections devoted 
to the causes of the drugs administration, the medications’ efficacy appraisal, their safety 
assessment, the awareness of maximum doses existence, the comparison of NSAIDs and 
paracetamol preparations application, combinations of various formulations, the issue of 
drinking alcohol at the time of the drugs utilization, habits of reading medicines package 
leaflets, information on medications obtained from pharmacists and physicians, and finally 
the matters of side effects. 
Table 1. The most popular formulations names of over-the counter (OTC) non-steroidal anti-inflammatory 
drugs (NSAIDs — Section A) and paracetamol (Section B) on the Polish market [6].
SECTION A
Advil Calcipiryna Meloxilek Pyralgin
Aleve Cefalgin Metafen Ring N
Alka-Prim Cholinex Miraspryn Sachol
Alka-Seltzer Dexak Modafen Salpirin
Anapiryna Dolores Moilec Saridon
Anapran Dexprofen Nalgesin Scorbolamid
Ascalcin Erka Naproxen Septolux
Ascodan Etopiryna Naxii Seractil
Aspicam Bio Excedrin Neopyrin ASA Strepsils
Aspirin Ibalgin Nurofen Tabletki przeciw grypie 
Aspirin Complex Ibum Opokan Tantum Verde
Asprocol Ibumax Panpiryna Upsarin 
Bestpirin Ibuprofen Paranalgin Vostar
Bolinet Ibuprom Polopiryna Voltaren
SECTION B
Acenol Codipar Gripblocker Pabitan
Analget Coldrex Gripex Panadol
Antidol Dafalgan Gripotaxin Paracetamol
Apap Efferalgan Grippokaps Solpadeine
Benuron Etoran Grippostad Tabcin
Calpol Febrisan Grypolek Tazamol
Cerugrip Fervex Grypostop Theraflu
Choligrip Flucontrol Novo-Gesic Vicks
The study group constituted 253 consecutive individuals but 3 of them (1.2%) declared 
they do not use OTC NSAIDs and paracetamol entirely. In effect, the analysis included 
250 students, who at least once a year use the surveyed drugs, aged 19–27 years (average 
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age: 22.1 ± 1.9 years; 61 men, 189 women). The study fields of the participants covered 
medicine, dentistry, economy, administration, environment protection, German, Polish or 
Arabic philology, law, fashion design, advertising, biotechnology, chemistry, physiotherapy, 
finances and banking, pedagogy, pharmacy, emergency medicine, history, nursery, manage-
ment and marketing, physics, geography, medical rehabilitation, science of commodities, 
power engineering, electronics and telecommunication. 
The statistical analysis was performed with the Statistica 10.0 PL version (Statsoft, Tulsa, 
USA). The Kolmogorov-Smirnov test was applied to examine a normal distribution. The mean 
values of certain parameters were compared with the use of the Student-t test or the Mann 
Whitney U test for the quantitative variables and chi-square test for qualitative variables. 
The statistical significance was considered when P <0.05. The data are presented as mean 
values ± standard deviation (SD) or as a percentage share of the patients in the analyzed 
groups. 
This study was performed in compliance with the Declaration of Helsinki.
Results 
Beside inflammatory disorders and fever NSAIDs and paracetamol were applied in clinical 
conditions in which those drugs should be avoided: asthma attack (in 1.2% of the study 
participants), vomiting (2.4%), malaise and depression (3.6%), in autumn and winter as 
a preventive measure against infections (14.0%), in heartburn (2.0%) and during food poi-
soning (16.0%, Table 2). 
As many as 84.4% of the students assessed the medications as efficient, whereas 13.2% 
claimed they have a poor curative effect and 3.6% of the survey participants perceived the 
drugs as devoid of therapeutic action. 
When the safety of the studied preparations was rated, 52.0% of the individuals appraised 
them as safe with occasional adverse effects and allergic reactions when administered with 
respect to safety measures of the producer. Almost two thirds (65.2%) of the respondents 
were aware that the risk of side effects increases with time of drug therapy and soaring 
medicines doses. Twenty nine per cent knew that in rare cases NSAIDs and paracetamol 
might be harmful, even though they are applied in right amounts. In the eyes of 6.0% of the 
students the drugs are ultimately free of adverse reactions. 
In the part of the study devoted to drugs doses limitations, 72.0% of the respondents 
were aware that although the medications are sold OTC, there is a maximum dose which 
should not be exceeded when combining different preparations within one group of the 
medicines. Fourteen per cent alleged that there is a maximum dose of each preparation but 
when needed one can use other related preparation. Over a half (53.2%) of the study group 
do not combine various NSAIDs or different paracetamol preparations, 24.0% utilize many 
NSAIDs and/or paracetamol drugs at the same time with the respect to the total maximum 
dose, whereas 23.2% might overdose medications of the same group, not paying attention 
to the combined doses limits. Almost one in five (18.0%) denied the existence of dose con-
straints in OTC preparations and 0.8% perceived them as absolutely harmless what makes 
their use unrestricted. 
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Table 2. The causes of the use of non-steroidal anti-inflammatory drugs (NSAIDs) and paracetamol.
Disorder NSAIDs paracetamol
Common cold           76.0%*           89.2%*
Sore throat           70.0%           75.2%
Tooth pain           64.8%           71.6%    
Diarrhea 8.8% 9.6%
Posttraumatic pain (e.g. ankle twist, sprain, contusion etc.)           64.4%           59.6%
Stomach ache in food intoxication           16.0%           14.4%
Headache           90.0%           91.8%
Hangover           20.0%           21.6%
Heartburn 2.0% 1.2%
Asthma 1.2% 0.8%
Hay fever 0.8% 1.6%
Allergic rash 2.0% 1.6%
Herpes 3.6% 4.0%
Earache           56.4%*           70.8%*
Muscle pain           24.4%*           16.8%*
Sciatica, lumbago, neuralgia etc.           18.8%           14.4%
Fever           86.0%*           92.0%*
Mood disturbance, depression 3.6% 3.2%
Vomiting 2.4% 0.8%
Autumn and winter time to prevent diseases           14.0%           12.0%
Constipation 2.4% 0.8%
Stressful situations (eg. exam at a university) 1.6% 2.4%
Painful menstruation (concerns only female respondents)           40.4%           46.8%
Renal colic, hepatic colic 0.4% 0.4%
Irritable bowel syndrome 2.4% 1.2%
Blood pressure surge 1.6% 0%
*p <0.05 for the comparison between NSAIDs and paracetamol
More that one third of the responders (35.2%) have a habit of taking NSAIDs and parac-
etamol on the occasion of alcohol consumption.
Answering the question about the practice of reading drugs package leaflets, only 36.0% 
of the students admit that they always look for preparations safety information and 4.0% 
complement their knowledge when they utilize a new medication. Another 39.2% do it ir-
regularly, 18.0% seldom and 3.2% never.
Considering the issue of a pharmacist informing buyers on NSAIDs and paracetamol 
contraindications, overdose and side effects, when the purchase is done at a pharmacy, 
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barely 4.0% of the survey participant have been always informed, 11.2% often, but 38.0% 
rarely and 46.8% never. The situation when a physician administers NSAIDs or paracetamol 
is not much better; hardly 8.0% always receive the necessary notices, 20.0% often, 43.0% 
rarely and 29.0% never.
In the comparison between NSAIDs and paracetamol utilization, 52.0% of the questioned 
use formulations of these two groups interchangeably, only 15.0% are aware of paracetamol 
lacking anti-inflammatory properties and 33.0% are convinced that paracetamol is better 
in combating inflammation. 
In the analysis of genders’ habits men more frequently than women used NSAIDs and 
paracetamol during alcohol consumption (49.2% vs 30.7%, p = 0.009, respectively) but 
less often were aware that there are maximum doses of medicines which should not be ex-
ceeded (57.4% vs 76.7%, p = 0.003, respectively). Medical, pharmacy, emergency medicine, 
medical rehabilitation and nursery students altogether (n = 82) compared with students of 
other fields of study (n = 168) were younger (20.9 ± 1.6 years vs 22.7 ± 2.2 years, p = 0.026) 
and declared they more often have the custom of always reading medication leaflets (46.3% 
vs 31.0%, p = 0.017, respectively).
Side effects of NSAIDs and paracetamol were reported by 65 participants — 26.0% (Table 3).
Table 3. Side effects of non-steroidal anti-inflammatory drugs (NSAIDs) and paracetamol.
Side effects NSAIDs Paracetamol
Nausea, vomiting, constipation, diarrhea 16.0%*   9.6%*
Heartburn and dyspeptic symptoms   6.8%*   1.2%*
Allergic rash, hay fever 2.4% 1.2%
Dizziness 7.0% 5.2%
Tinnitus, hearing disturbances   4.4%*   0.4%*
Blurred vision 3.2% 0.4%
Dyspnea, breathing problems 1.6% 0%
Symptoms leading to hospitalization 0% 0%
Discussion
The huge popularity of NSAIDs and paracetamol can be attributed to their effectiveness, 
but it is also evidence of the power and impact of advertising sponsored by pharmaceuti-
cal companies [9, 17]. The dark and hardly publicized by medicines manufacturers side of 
NSAIDs and paracetamol are hospitalizations associated with the occurrence of complica-
tions related to the drugs, reaching 100 thousand cases in USA each year [18]. OTC NSAIDs 
were found to be the most common cause of peptic ulcer disease and a source of gastroin-
testinal bleeding within elderly patients [19]. They are the second most common cause of 
drug-induced hypersensitivity reactions and are responsible for 21–25% of reported adverse 
drug events [20]. NSAID hypersensitivity is particularly manifested clinically by bronchial 
*p <0.05 for the comparison between NSAIDs and paracetamol
Jerzy Wiliński, Marta Lechowicz, et al.
55
asthma, rhinosinusitis or urticaria and variety of late cutaneous and organ-specific reac-
tions. Severe reactions include anaphylaxis, Stevens Johnson syndrome and toxic epidermal 
necrolysis and are associated with significant mortality [21]. Moreover, negative impact of 
selective cyclo-oxygenase-2 inhibitors — coxibs and other NSAIDs, associated with impaired 
balance between thromboxane and prostacycline, perturbed prostaglandins synthesis and 
lipid oxidation process, lead to thromboembolic complications, arterial hypertension, ath-
erosclerosis causing increased rates of myocardial infarction, ischemic stroke, peripheral 
vessels thrombosis and pulmonary embolism [22–24]. NSAIDs decrease sodium excretion 
by kidneys what soars blood pressure. They can also cause analgesic nephropathy [25]. 
OTC relative safety in terms of severe complications was confirmed in our survey in which 
none of the participants has ever needed urgent medical care.
Paracetamol therapy is associated with rare complications what was also reflected in 
our study. Apart from rash and mild symptoms from the gastrointestinal tract and casuistic 
examples of hematological disorders, the fact of overdose leading to severe liver failure and 
even death of the patient is commonly known [6, 26, 27]. 
The problem of drug consumption by young people does not arouse such interest, but 
it should be emphasized that precisely at this age the attitudes of behavior for life, including 
medicines use, are shaped. Moreover, some of the interrogated students of medical fields 
might play roles in governing bodies in health policy in the future or act as health educa-
tors [28]. Furthermore, in the presented study almost all of young adults (98.8%) confirmed 
the active use of OTC NSAIDs and paracetamol which is coherent with the observations of 
Plichta et al. of students of public health who all and sundry have ever taken such drugs and 
more common than in older people of general populations (71–85%) [24, 29, 30].
We have investigated that students in the self-treatment of different disorders hardly ever 
read drugs leaflets and seldom receive any information on drug related endangerments from 
physicians and pharmacists. As other studies show package inserts are ignored by 25–50% of 
the medications users, drug leaflets do not comply with the European Union formal regula-
tions and use difficult language with specialized terms what makes them incomprehensible to 
even 40% of people including those with university education [31–34]. This is also consistent 
with the Czech study on non-prescription ibuprofen which showed that only one third of 
new users of the medicine consult with a physician prior obtaining it, while generally 40% 
of participants do not ask for any information regarding the drugs [35]. 
We also encountered students who were convinced that NSAIDs and paracetamol have 
no side effects. Similar observations come from papers of Reguła et al. and Matoulková et 
al., where similarly around 16% of the subjects shared the same belief [36, 37].
Unfortunately, significant portion of young and healthy students suffer from NSAIDs and 
paracetamol adverse reactions — from 26.0% in our study up to 28.0% in Turkish medical 
students and 30.4% in young Poles [38, 39]. The scale of the problem in general popula-
tion is greater as show the results of the interview-based study of Albsoul-Younes et al. in 
which more than a half of participants (58%) reported having side effects upon NSAIDs 
consumption with gastrointestinal symptoms as the most common upset [40]. Noteworthy, 
NSAIDs complications have a poor correlation with clinical presentation — in many cases 
dyspeptic symptoms are not associated with significant endoscopic lesions while even in 
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40% of patients with chronic NSAIDs pharmacotherapy are detected to have asymptomatic 
gastric or duodenal ulcers [41, 42]. As Polish survey on over 38,000 participants show, only 
60% of the individuals who reported at least one potential adverse reaction were aware that 
it might be the effect of prolonged NSAIDs treatment [37].
Alarmingly, we also have discovered that the medication group choice for the giv-
en disorder is often inappropriate and the drugs are applied in conditions in which they 
are contraindicated what is in concordance with observations of the survey of Ngo et al. 
in which the majority of patients had no knowledge about indications of ibuprofen [43]. 
Kozłowski and colleagues investigated that only 38% of the surveyed OTC painkillers 
buyers know what analgesic substance they are receiving [34]. In the aforementioned 
study of Matoulková et al. two per cent of participants even believed that ibuprofen was 
a sleeping aid [36]. This ignorance might lead to inadvertent combinations of drugs of 
one group or the same compound with different trade names, what was validated in 
our survey. 
A potentially harmful composition of NSAIDS or paracetamol and alcohol might 
lead to liver failure, blood coagulation disturbances and increases the risk of gastroin-
testinal bleeding, especially in patients with chronic diseases and is observed not only in 
students but in remarkable numbers of people in general population trials reaching 40% 
[34, 44].
Interestingly, paracetamol was more eagerly chosen by our respondents to treat inflam-
matory diseases than NSAIDs like in common cold, what in theory could be less efficient 
but as clinical trails show is not necessarily inferior [45]. The students seldom combined 
NSAIDs and paracetamol, using their adjunctive actions [46, 47].
Gender affects different aspects of drug consumption. In the Czech survey men used 
pharmacists’ counseling about OTC drugs significantly more often than women and in the 
Polish one by Plichta and colleagues men’s knowledge on such medicines was more frequently 
based on television commercials [28, 36]. Differences in our study concerned prevalent drug 
consumption at the time of medicaments utilization in male respondents and their lower 
awareness of maximum doses of the drugs existence.
Summing up, low level of knowledge seems to be a global issue. In other studies young 
age and higher level of education correlated with better awareness of various aspects of 
NSAIDs therapy [36]. Unfortunately, in the presented survey the comparison of medical 
and pharmacy students with other participants shows that medical fields of study as op-
posed to others do not guarantee markedly more aware and safer OTC drugs consumption 
practice. 
In conclusion, students’ knowledge about OTC NSAIDs and paracetamol is low. Partic-
ipants do not search for information on drug related endangerments, the medication group 
choice for the given disorder is often inappropriate and the drugs are applied in conditions 
in which they are contraindicated. 
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